Search research articles
Contact Us
Filters
Showing results (171-180 of 273) with videos related to
Page
of 28
Sort By:
Blood
|
January 29, 2010
Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis
Julia A Brown, Kristen Stevenson, Haesook T Kim, et al.
Cancer
|
September 11, 2014
Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma
Yi-Bin Chen, Tracy Batchelor, Shuli Li, et al.
Hemasphere
|
April 3, 2024
Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma
Reid W Merryman, Justin Rhoades, Kan Xiong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 31, 2011
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation
Caron A Jacobson, Amin T Turki, Sean M McDonough, et al.
Blood
|
July 31, 2020
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Nancy L Bartlett, Alex F Herrera, Eva Domingo-Domenech, et al.
JCI Insight
|
November 5, 2016
Low-dose IL-2 selectively activates subsets of CD4<sup>+</sup> Tregs and NK cells
Masahiro Hirakawa, Tiago R Matos, Hongye Liu, et al.
Open Forum Infectious Diseases
|
August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies
Amy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
British Journal of Haematology
|
January 6, 2016
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
Philippe Armand, Haesook T Kim, Marie-Michele Sainvil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2019
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study
Radhakrishnan Ramchandren, Eva Domingo-Domènech, Antonio Rueda, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 273) with videos related to
Sort By:
Page
of 28
Blood
|
January 29, 2010
Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis
Julia A Brown, Kristen Stevenson, Haesook T Kim, et al.
Cancer
|
September 11, 2014
Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma
Yi-Bin Chen, Tracy Batchelor, Shuli Li, et al.
Hemasphere
|
April 3, 2024
Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma
Reid W Merryman, Justin Rhoades, Kan Xiong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 31, 2011
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation
Caron A Jacobson, Amin T Turki, Sean M McDonough, et al.
Blood
|
July 31, 2020
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Nancy L Bartlett, Alex F Herrera, Eva Domingo-Domenech, et al.
JCI Insight
|
November 5, 2016
Low-dose IL-2 selectively activates subsets of CD4<sup>+</sup> Tregs and NK cells
Masahiro Hirakawa, Tiago R Matos, Hongye Liu, et al.
Open Forum Infectious Diseases
|
August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies
Amy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
British Journal of Haematology
|
January 6, 2016
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
Philippe Armand, Haesook T Kim, Marie-Michele Sainvil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2019
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study
Radhakrishnan Ramchandren, Eva Domingo-Domènech, Antonio Rueda, et al.
Page
of 28